Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifschytz

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Israel Journal of Psychiatry and Related Sciences|July 1, 2016
Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients with Major Depressive Disorder: A Preliminary Randomized Controlled TrialTal Shachar-Malach, Rena Cooper Kazaz, Naama Constantini, et al.
Brain Research Bulletin|January 29, 2018
Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamineAnastasia Hodes, Tzuri Lifschytz, Haim Rosen, et al.
Bipolar Disorders|July 10, 2016
Endogenous cardiac steroids in animal models of maniaAnastasia Hodes, Haim Rosen, Joseph Deutsch, et al.
Molecular Psychiatry|September 2, 2025
Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)"Michal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
The International Journal of Neuropsychopharmacology|October 20, 2009
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting propertiesRenana Eitan, Galit Landshut, Tzuri Lifschytz, et al.
Translational Psychiatry|June 13, 2025
Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administrationTom Ben-Tal, Ilana Pogodin, Alexander Botvinnik, et al.
Psychoneuroendocrinology|June 29, 2004
Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramineEitan Gur, Tsuri Lifschytz, Louis D Van De Kar, et al.
The International Journal of Neuropsychopharmacology|March 29, 2025
Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatmentMichal Lazar, Michal Brownstien, Alexander Botvinnik, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2011
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse modelLior Greenbaum, Tzuri Lifschytz, Polina Zozulinsky, et al.
Current Drug Targets|February 16, 2006
Basic mechanisms of augmentation of antidepressant effects with thyroid hormoneTsuri Lifschytz, Ronen Segman, Galit Shalom, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Israel Journal of Psychiatry and Related Sciences|July 1, 2016
Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients with Major Depressive Disorder: A Preliminary Randomized Controlled TrialTal Shachar-Malach, Rena Cooper Kazaz, Naama Constantini, et al.
Brain Research Bulletin|January 29, 2018
Reduction in endogenous cardiac steroids protects the brain from oxidative stress in a mouse model of mania induced by amphetamineAnastasia Hodes, Tzuri Lifschytz, Haim Rosen, et al.
Bipolar Disorders|July 10, 2016
Endogenous cardiac steroids in animal models of maniaAnastasia Hodes, Haim Rosen, Joseph Deutsch, et al.
Molecular Psychiatry|September 2, 2025
Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)"Michal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
The International Journal of Neuropsychopharmacology|October 20, 2009
The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting propertiesRenana Eitan, Galit Landshut, Tzuri Lifschytz, et al.
Translational Psychiatry|June 13, 2025
Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administrationTom Ben-Tal, Ilana Pogodin, Alexander Botvinnik, et al.
Psychoneuroendocrinology|June 29, 2004
Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramineEitan Gur, Tsuri Lifschytz, Louis D Van De Kar, et al.
The International Journal of Neuropsychopharmacology|March 29, 2025
Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatmentMichal Lazar, Michal Brownstien, Alexander Botvinnik, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2011
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse modelLior Greenbaum, Tzuri Lifschytz, Polina Zozulinsky, et al.
Current Drug Targets|February 16, 2006
Basic mechanisms of augmentation of antidepressant effects with thyroid hormoneTsuri Lifschytz, Ronen Segman, Galit Shalom, et al.
Pageof 7